These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27073470)

  • 21. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes.
    Kang OH; Kim SB; Mun SH; Seo YS; Hwang HC; Lee YM; Lee HS; Kang DG; Kwon DY
    Int J Mol Med; 2015 Mar; 35(3):803-9. PubMed ID: 25605057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-lipoapoptotic effects of Alisma orientalis extract on non-esterified fatty acid-induced HepG2 cells.
    Jeong HS; Cho YH; Kim KH; Kim Y; Kim KS; Na YC; Park J; Lee IS; Lee JH; Jang HJ
    BMC Complement Altern Med; 2016 Jul; 16():239. PubMed ID: 27456850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accumulation of lipids and oxidatively damaged DNA in hepatocytes exposed to particles.
    Vesterdal LK; Danielsen PH; Folkmann JK; Jespersen LF; Aguilar-Pelaez K; Roursgaard M; Loft S; Møller P
    Toxicol Appl Pharmacol; 2014 Jan; 274(2):350-60. PubMed ID: 24121055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrophilic nitro-oleic acid reverses obesity-induced hepatic steatosis.
    Khoo NKH; Fazzari M; Chartoumpekis DV; Li L; Guimaraes DA; Arteel GE; Shiva S; Freeman BA
    Redox Biol; 2019 Apr; 22():101132. PubMed ID: 30769284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperglycemia induces key genetic and phenotypic changes in human liver epithelial HepG2 cells which parallel the Leprdb/J mouse model of non-alcoholic fatty liver disease (NAFLD).
    Su RC; Lad A; Breidenbach JD; Blomquist TM; Gunning WT; Dube P; Kleinhenz AL; Malhotra D; Haller ST; Kennedy DJ
    PLoS One; 2019; 14(12):e0225604. PubMed ID: 31805072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oleic acid-induced hepatic steatosis is coupled with downregulation of aquaporin 3 and upregulation of aquaporin 9 via activation of p38 signaling.
    Gu LY; Qiu LW; Chen XF; Lü L; Mei ZC
    Horm Metab Res; 2015 Apr; 47(4):259-64. PubMed ID: 25105540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells.
    Cui W; Chen SL; Hu KQ
    Am J Transl Res; 2010 Jan; 2(1):95-104. PubMed ID: 20182586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic STAMP2 alleviates high fat diet-induced hepatic steatosis and insulin resistance.
    Kim HY; Park SY; Lee MH; Rho JH; Oh YJ; Jung HU; Yoo SH; Jeong NY; Lee HJ; Suh S; Seo SY; Cheong J; Jeong JS; Yoo YH
    J Hepatol; 2015 Aug; 63(2):477-85. PubMed ID: 25646886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracts from Aralia elata (Miq) Seem alleviate hepatosteatosis via improving hepatic insulin sensitivity.
    Hwang KA; Hwang YJ; Kim GR; Choe JS
    BMC Complement Altern Med; 2015 Oct; 15():347. PubMed ID: 26438035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells.
    Rogue A; Anthérieu S; Vluggens A; Umbdenstock T; Claude N; de la Moureyre-Spire C; Weaver RJ; Guillouzo A
    Toxicol Appl Pharmacol; 2014 Apr; 276(1):73-81. PubMed ID: 24534255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells.
    Zeng L; Tang W; Yin J; Feng L; Li Y; Yao X; Zhou B
    Cell Physiol Biochem; 2016; 40(3-4):453-464. PubMed ID: 27889747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oleic acid ameliorates palmitic acid induced hepatocellular lipotoxicity by inhibition of ER stress and pyroptosis.
    Zeng X; Zhu M; Liu X; Chen X; Yuan Y; Li L; Liu J; Lu Y; Cheng J; Chen Y
    Nutr Metab (Lond); 2020; 17():11. PubMed ID: 32021639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Porphyromonas gingivalis-derived lipopolysaccharide causes excessive hepatic lipid accumulation via activating NF-κB and JNK signaling pathways.
    Ding LY; Liang LZ; Zhao YX; Yang YN; Liu F; Ding QR; Luo LJ
    Oral Dis; 2019 Oct; 25(7):1789-1797. PubMed ID: 31283861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of sera of rats fed with
    Yang M; Chen Z; Xiao C; Tang W; Zhou B
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Nov; 38(11):1277-1287. PubMed ID: 30514673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytochrome P450 1A1 (CYP1A1) Catalyzes Lipid Peroxidation of Oleic Acid-Induced HepG2 Cells.
    Huang B; Bao J; Cao YR; Gao HF; Jin Y
    Biochemistry (Mosc); 2018 May; 83(5):595-602. PubMed ID: 29738693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells.
    Yoon S; Kim J; Lee H; Lee H; Lim J; Yang H; Shin SS; Yoon M
    J Ethnopharmacol; 2017 Jan; 195():204-213. PubMed ID: 27845265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice.
    Rom O; Xu G; Guo Y; Zhu Y; Wang H; Zhang J; Fan Y; Liang W; Lu H; Liu Y; Aviram M; Liu Z; Kim S; Liu W; Wang X; Chen YE; Villacorta L
    EBioMedicine; 2019 Mar; 41():62-72. PubMed ID: 30772307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel sesquiterpene glycoside from Loquat leaf alleviates oleic acid-induced steatosis and oxidative stress in HepG2 cells.
    Jian T; Wu Y; Ding X; Lv H; Ma L; Zuo Y; Ren B; Zhao L; Tong B; Chen J; Li W
    Biomed Pharmacother; 2018 Jan; 97():1125-1130. PubMed ID: 29136950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dihydrocurcumin ameliorates the lipid accumulation, oxidative stress and insulin resistance in oleic acid-induced L02 and HepG2 cells.
    Yu Q; Liu Y; Wu Y; Chen Y
    Biomed Pharmacother; 2018 Jul; 103():1327-1336. PubMed ID: 29864915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cilostazol Improves HFD-Induced Hepatic Steatosis by Upregulating Hepatic STAMP2 Expression through AMPK.
    Oh YJ; Kim HY; Lee MH; Suh SH; Choi Y; Nam TG; Kwon WY; Lee SY; Yoo YH
    Mol Pharmacol; 2018 Dec; 94(6):1401-1411. PubMed ID: 30366981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.